In certain cases, regulators will now be open to clearing therapies based on their ability to eliminate tumor cells, a change ...
Personalized clinical research is gaining momentum as the limitations of population-based studies in guiding individual ...
Brainomix, a global leader and pioneer of AI-powered imaging tools in lung fibrosis and stroke, today announced it was ...
Merck's CEO Rob Davis emphasizes DEI as a strategic imperative, aligning it with scientific rigor and innovation, showcasing ...
Objective This systematic review aims to evaluate the effectiveness of exercise interventions in alleviating depression and ...
One of the Trial objectives that shows up after the ARC Raiders weekly reset is " deal damage to Queens or Matriarchs ." This ...
South Korea's impeached president Yoon Suk Yeol will be jailed for five years over abuse of power, obstructing justice and ...
The SFDA reported that approximately 2,700 patients have benefited from access to innovative and advanced treatments through ...
Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...
Bitopertin was awarded the Commissioner’s National Priority Review Voucher (CNPV) and NDA is currently under FDA reviewUpdated data from the ...
PE: How can teams reduce patient burden without weakening their science? Schwab: Number one is lean trial design. We should ...
Abstract: Multi-objective reinforcement learning (MORL) is a structured approach for optimizing tasks with multiple objectives. However, it often relies on pre-defined reward functions, which can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results